← All trials
NCT07278505
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 28, 2025
- Primary completion
- Feb 28, 2030
- Completion date
- Feb 28, 2030
- First posted
- Dec 12, 2025
- Last posted
- Dec 12, 2025
- Enrollment
- 160
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Icahn School of Medicine at Mount SinaiLead sponsor
- Icahn School of Medicine at Mount SinaiSponsor investigator
- Icahn School of Medicine at Mount SinaiOfficial
- Jazz PharmaceuticalsCollaborator
- National Institute of Mental Health (NIMH)Collaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.